Exploring LIT Therapy: A Promising Treatment for Recurrent Pregnancy Loss

A smiling couple, seated and embracing, looks at a pregnancy test with joy.

The journey to parenthood can be marred by the heartbreak of recurrent pregnancy loss (RPL), affecting approximately 5% of women. Among the various treatment options, Lymphocyte Immunization Therapy (LIT) stands out as a hopeful solution based on immunological principles. This article delves into the science behind LIT, exploring its potential benefits, limitations, and the hope it offers to couples grappling with RPL and unexplained infertility.

  • Reduced Miscarriage Risk: By modulating the maternal immune response to paternal antigens, LIT may decrease miscarriage rates.
  • Enhanced Implantation Rates: Immunological tolerance induced by LIT could improve the likelihood of successful embryo implantation.
  • Increased Live Birth Rates: For couples with recurrent implantation failures linked to immunological issues, LIT offers a potential increase in live birth rates.
  • Minimally Invasive: The procedure involves a simple blood draw, making it a less invasive option for the woman.
  • Local Reactions: Mild symptoms such as redness or swelling at the injection site, usually transient and manageable.
  • Systemic Reactions: Rare, mild systemic reactions like fever or malaise may occur.
  • Allergic Reactions: Though rare, it’s important to monitor for any signs of allergy and seek immediate medical help if severe symptoms appear.
Scroll to Top